Recent research highlights the role of sensory nerves in promoting breast cancer metastasis. By secreting neuropeptides, these nerves enhance tumor growth and spread, revealing a potential new therapeutic target. The study shows that the FDA-approved drug aprepitant can inhibit this pathway, reducing metastasis in breast cancer models. This breakthrough underscores the critical link between the nervous system and cancer, offering new avenues for treatment.

A new experimental cancer drug could ease cognitive difficulties for those with Rett syndrome, a rare autism-linked disorder, by enhancing brain cell functions. The drug, ADH-503, improves the activity of microglia, which are crucial for maintaining neural networks.

Researchers developed a new method, burst sine wave electroporation (B-SWE), to treat glioblastoma, a fast-growing brain tumor. B-SWE disrupts the blood-brain barrier more effectively than traditional methods, allowing cancer drugs better access to the brain.